Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers

Male breast cancer represents about 1% of all breast cancer diagnoses and, although there are some similarities between male and female breast cancer, the paucity of data available on male breast cancer makes it difficult to establish targeted therapies. To date, most male breast cancers (MBCs) are...

Full description

Bibliographic Details
Main Authors: Hyunsoo Kim, Kamila Wisniewska, Matthew J. Regner, Aatish Thennavan, Philip M. Spanheimer, Hector L. Franco
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/17/13053
_version_ 1797582472927510528
author Hyunsoo Kim
Kamila Wisniewska
Matthew J. Regner
Aatish Thennavan
Philip M. Spanheimer
Hector L. Franco
author_facet Hyunsoo Kim
Kamila Wisniewska
Matthew J. Regner
Aatish Thennavan
Philip M. Spanheimer
Hector L. Franco
author_sort Hyunsoo Kim
collection DOAJ
description Male breast cancer represents about 1% of all breast cancer diagnoses and, although there are some similarities between male and female breast cancer, the paucity of data available on male breast cancer makes it difficult to establish targeted therapies. To date, most male breast cancers (MBCs) are treated according to protocols established for female breast cancer (FBC). Thus, defining the transcriptional and epigenetic landscape of MBC with improved resolution is critical for developing better avenues for therapeutic intervention. In this study, we present matched transcriptional (scRNA-seq) and epigenetic (scATAC-seq) profiles at single-cell resolution of two treatment naïve MBC tumors processed immediately after surgical resection. These data enable the detection of differentially expressed genes between male and female breast tumors across immune, stromal, and malignant cell types, to highlight several genes that may have therapeutic implications. Notably, <i>MYC</i> target genes and <i>mTORC1</i> signaling genes were significantly upregulated in the malignant cells of MBC compared to the female counterparts. To understand how the regulatory landscape of MBC gives rise to these male-specific gene expression patterns, we leveraged the scATAC-seq data to systematically link changes in chromatin accessibility to changes in gene expression within each cell type. We observed cancer-specific rewiring of several salient enhancers and posit that these enhancers have a higher regulatory load than lineage-specific enhancers. We highlight two examples of previously unannotated cancer-cell-specific enhancers of <i>ANXA2</i> and <i>PRDX4</i> gene expression and show evidence for super-enhancer regulation of <i>LAMB3</i> and <i>CD47</i> in male breast cancer cells. Overall, this dataset annotates clinically relevant regulatory networks in male breast tumors, providing a useful resource that expands our current understanding of the gene expression programs that underlie the biology of MBC.
first_indexed 2024-03-10T23:22:49Z
format Article
id doaj.art-a669c4bf6d75475b99451811a54a7867
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T23:22:49Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a669c4bf6d75475b99451811a54a78672023-11-19T08:11:44ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-08-0124171305310.3390/ijms241713053Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific EnhancersHyunsoo Kim0Kamila Wisniewska1Matthew J. Regner2Aatish Thennavan3Philip M. Spanheimer4Hector L. Franco5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USALineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USALineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USALineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USALineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USALineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USAMale breast cancer represents about 1% of all breast cancer diagnoses and, although there are some similarities between male and female breast cancer, the paucity of data available on male breast cancer makes it difficult to establish targeted therapies. To date, most male breast cancers (MBCs) are treated according to protocols established for female breast cancer (FBC). Thus, defining the transcriptional and epigenetic landscape of MBC with improved resolution is critical for developing better avenues for therapeutic intervention. In this study, we present matched transcriptional (scRNA-seq) and epigenetic (scATAC-seq) profiles at single-cell resolution of two treatment naïve MBC tumors processed immediately after surgical resection. These data enable the detection of differentially expressed genes between male and female breast tumors across immune, stromal, and malignant cell types, to highlight several genes that may have therapeutic implications. Notably, <i>MYC</i> target genes and <i>mTORC1</i> signaling genes were significantly upregulated in the malignant cells of MBC compared to the female counterparts. To understand how the regulatory landscape of MBC gives rise to these male-specific gene expression patterns, we leveraged the scATAC-seq data to systematically link changes in chromatin accessibility to changes in gene expression within each cell type. We observed cancer-specific rewiring of several salient enhancers and posit that these enhancers have a higher regulatory load than lineage-specific enhancers. We highlight two examples of previously unannotated cancer-cell-specific enhancers of <i>ANXA2</i> and <i>PRDX4</i> gene expression and show evidence for super-enhancer regulation of <i>LAMB3</i> and <i>CD47</i> in male breast cancer cells. Overall, this dataset annotates clinically relevant regulatory networks in male breast tumors, providing a useful resource that expands our current understanding of the gene expression programs that underlie the biology of MBC.https://www.mdpi.com/1422-0067/24/17/13053breast cancermale breast cancersingle-cell genomicsscRNA-seqscATAC-seqintratumoral heterogeneity
spellingShingle Hyunsoo Kim
Kamila Wisniewska
Matthew J. Regner
Aatish Thennavan
Philip M. Spanheimer
Hector L. Franco
Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
International Journal of Molecular Sciences
breast cancer
male breast cancer
single-cell genomics
scRNA-seq
scATAC-seq
intratumoral heterogeneity
title Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
title_full Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
title_fullStr Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
title_full_unstemmed Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
title_short Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
title_sort single cell transcriptional and epigenetic profiles of male breast cancer nominate salient cancer specific enhancers
topic breast cancer
male breast cancer
single-cell genomics
scRNA-seq
scATAC-seq
intratumoral heterogeneity
url https://www.mdpi.com/1422-0067/24/17/13053
work_keys_str_mv AT hyunsookim singlecelltranscriptionalandepigeneticprofilesofmalebreastcancernominatesalientcancerspecificenhancers
AT kamilawisniewska singlecelltranscriptionalandepigeneticprofilesofmalebreastcancernominatesalientcancerspecificenhancers
AT matthewjregner singlecelltranscriptionalandepigeneticprofilesofmalebreastcancernominatesalientcancerspecificenhancers
AT aatishthennavan singlecelltranscriptionalandepigeneticprofilesofmalebreastcancernominatesalientcancerspecificenhancers
AT philipmspanheimer singlecelltranscriptionalandepigeneticprofilesofmalebreastcancernominatesalientcancerspecificenhancers
AT hectorlfranco singlecelltranscriptionalandepigeneticprofilesofmalebreastcancernominatesalientcancerspecificenhancers